top of page

Search

NEW EVENT: Exploring the Role of NUBEQA (darolutamide) in mHSPC in Combination with Docetaxel and in nmCRPC PP-NUM-US-3389-1

Social Media Coordinator
Apr 12
1 min read

Check out this new event and grab a seat!

Recent Posts

CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's

CAR-Therapy Adverse Reaction Identification and Management Considerations ~ Thursday, June 12th @ Davio's

NOW HYBRID! Join BONS for another FREE CNE event sponsored by CEC Oncology

NOW HYBRID! Join BONS for another FREE CNE event sponsored by CEC Oncology

BONS Half Day Seminar ~ It's around the corner

BONS Half Day Seminar ~ It's around the corner

Comments

bottom of page